Pfizer Inc. (PFE)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
Pre-market:
Show:
Annual
Income statement
All numbers in thousandsBreakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
92,433,000
81,288,000
41,908,000
51,750,000
53,647,000
Cost of revenue
36,648,000
30,821,000
8,692,000
10,219,000
11,248,000
Gross profit
55,785,000
50,467,000
33,216,000
41,531,000
42,399,000
Operating expenses
Research development
14,136,000
13,829,000
9,405,000
8,650,000
8,006,000
Selling general and administrative
12,519,000
12,703,000
11,615,000
14,350,000
14,455,000
Total operating expenses
30,332,000
30,232,000
24,456,000
27,610,000
27,354,000
Operating income or loss
25,453,000
20,235,000
8,760,000
13,921,000
15,045,000
Interest expense
1,277,000
1,291,000
1,449,000
1,574,000
1,316,000
Total other income/expenses net
3,446,000
5,331,000
113,000
5,108,000
-2,178,000
Income before tax
27,669,000
24,311,000
7,497,000
17,682,000
11,885,000
Income tax expense
2,216,000
1,852,000
477,000
1,384,000
706,000
Income from continuing operations
25,453,000
22,459,000
7,021,000
16,298,000
11,179,000
Net income
24,966,000
21,979,000
9,616,000
16,273,000
11,153,000
Net income available to common shareholders
24,966,000
21,979,000
9,616,000
16,272,000
11,152,000
Basic EPS
-
3.92
1.73
2.92
1.90
Diluted EPS
-
3.85
1.71
2.87
1.87
Basic average shares
-
5,601,000
5,555,000
5,569,000
5,872,000
Diluted average shares
-
5,708,000
5,632,000
5,675,000
5,977,000
EBITDA
-
30,793,000
13,723,000
25,266,000
19,585,000
© 2022 Yahoo. All rights reserved.
